Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SocraTec R&D is a specialized European contract research organization (CRO) providing comprehensive clinical development services for the pharmaceutical and biotech industries. The company focuses on early-phase clinical trials, including Phase I and Phase II studies, with particular expertise in pharmacokinetics, bioequivalence, and complex clinical pharmacology. Beyond clinical operations, SocraTec offers strategic regulatory consulting, medical writing, and data management services to support drug development from concept to market authorization. Their service portfolio is designed to bridge the gap between preclinical research and late-stage clinical development through high-quality scientific and regulatory expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SocraTec R&D Concepts.